Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IDEXX Laboratories, Inc. (IDXX : NSDQ)
 
 • Company Description   
IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Number of Employees: 11,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $634.90 Daily Weekly Monthly
20 Day Moving Average: 509,003 shares
Shares Outstanding: 79.85 (millions)
Market Capitalization: $50,697.61 (millions)
Beta: 1.67
52 Week High: $769.98
52 Week Low: $356.14
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.84% -8.91%
12 Week -16.01% -16.85%
Year To Date -6.15% -6.64%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
ONE IDEXX DRIVE
-
WESTBROOK,ME 04092
USA		 ph: 207-556-0300
fax: 207-556-4346		 investorrelations@idexx.com http://www.idexx.com
 
 • General Corporate Information   
Officers
Jonathan J. Mazelsky - President; Chief Executive Officer and Director
Lawrence D. Kingsley - Chairman
Brian P. McKeon - Executive Vice President; Chief Financial Officer
Irene Chang Britt - Director
Bruce L. Claflin - Director

Peer Information
IDEXX Laboratories, Inc. (ABMD)
IDEXX Laboratories, Inc. (DMDS)
IDEXX Laboratories, Inc. (CPWY.)
IDEXX Laboratories, Inc. (EQUR)
IDEXX Laboratories, Inc. (ECIA)
IDEXX Laboratories, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 45168D104
SIC: 2835
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/07/26
Share - Related Items
Shares Outstanding: 79.85
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.67
Market Capitalization: $50,697.61 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $3.45 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $14.52 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 11.32% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/07/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 43.72
Trailing 12 Months: 48.58
PEG Ratio: 3.86
Price Ratios
Price/Book: 31.58
Price/Cash Flow: 42.90
Price / Sales: 11.78
EPS Growth
vs. Year Ago Period: 17.56%
vs. Previous Quarter: -9.41%
Sales Growth
vs. Year Ago Period: 14.28%
vs. Previous Quarter: -1.33%
ROE
12/31/25 - 69.78
09/30/25 - 67.78
06/30/25 - 64.42
ROA
12/31/25 - 31.91
09/30/25 - 31.08
06/30/25 - 29.89
Current Ratio
12/31/25 - 1.23
09/30/25 - 1.18
06/30/25 - 1.11
Quick Ratio
12/31/25 - 0.90
09/30/25 - 0.87
06/30/25 - 0.79
Operating Margin
12/31/25 - 24.62
09/30/25 - 24.65
06/30/25 - 24.41
Net Margin
12/31/25 - 24.62
09/30/25 - 24.65
06/30/25 - 24.41
Pre-Tax Margin
12/31/25 - 30.77
09/30/25 - 30.56
06/30/25 - 30.41
Book Value
12/31/25 - 20.10
09/30/25 - 19.55
06/30/25 - 18.23
Inventory Turnover
12/31/25 - 4.22
09/30/25 - 4.09
06/30/25 - 3.98
Debt-to-Equity
12/31/25 - 0.23
09/30/25 - 0.24
06/30/25 - 0.31
Debt-to-Capital
12/31/25 - 18.93
09/30/25 - 19.36
06/30/25 - 23.57
 

Powered by Zacks Investment Research ©